Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes

Society: DDW

While attending DDW 2025, join us for this complimentary CME program to discover the impact of IBS-C on patients' QoL and find out how to apply advances in its treatment & management. Irritable bowel syndrome with constipation (IBS-C) presents a complex challenge, impacting patients physically, psychologically, and socially. Traditional treatments often fall short, leaving many with persistent symptoms and reduced quality of life. Join our live symposium for a deep dive into the multifactorial pathophysiology of IBS-C, the latest clinical insights, and emerging treatment strategies to enhance patient care. Don't miss this opportunity to gain practical, expert-driven guidance on optimizing IBS-C management. Program Schedule* 6:00pm – 6:30pm: Registration and Dinner 6:30pm – 6:35pm: Welcome and Introductions 6:35pm – 6:50pm: Understanding the Full Impact of IBS-C: Patient Quality of Life and the Limitations of Current IBS-C Management Strategies 6:50pm – 7:05pm: The Science Behind IBS-C: Linking Pathophysiology to Treatment 7:05pm – 7:20pm: New Horizons in IBS-C Treatment: Assessing FDA-Approved Medications Chair: Darren M. Brenner, MD, AGAF, FACG, RFF Professor of Medicine Northwestern University Chicago, IL Faculty: William D. Chey, MD, AGAF, FACG, FACP, RFF H. Marvin Pollard Professor of Gastroenterology Professor of Nutrition Sciences Chief, Division of Gastroenterology Michigan Medicine Ann Arbor, MI Faculty: Kimberly D. Orleck, PA-C Director of Advanced Practice Providers Atlanta Gastroenterology Associates Atlanta, GA This activity is supported by an independent educational grant from Ardelyx, Inc.